USRM — US Stem Cell Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for US Stem Cell, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1.36	0	0.019	0.039	0.005
Net Total Accounts Receivable
Net Total Receivables	0.018	0.048	0.054	0.001	0.004
Total Inventory
Prepaid Expenses
Total Current Assets	1.51	0.066	0.088	0.051	0.068
Net Property, Plant And Equipment	0.243	0	—	—	—
Long Term Investments
Other Long Term Assets
Total Assets	1.82	0.09	0.088	0.051	0.068
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5.92	8.75	10.8	12	14.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	8.7	9.57	11.7	12.8	14.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-6.88	-9.48	-11.6	-12.8	-14.7
Total Liabilities & Shareholders' Equity	1.82	0.09	0.088	0.051	0.068
Total Common Shares Outstanding
Total Preferred Shares Outstanding